Opendata, web and dolomites

NIGHTWATCH SIGNED

NightWatch - Clinically-proven detection and alert system for critical nocturnal epileptic seizures.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 NIGHTWATCH project word cloud

Explore the words cloud of the NIGHTWATCH project. It provides you a very rough idea of what is the project "NIGHTWATCH" about.

care    social    registered    mind    north    quality    alarm    medical    dutch    automatically    false    continuous    relief    40    pushing    preferred    wirelessly    2019    28    monitor    seizure    seconds    created    caregivers    societal    30    life    patients    types    home    reducing    uncontrolled    spin    sudep    livassured    rate    algorithm    notifies    followed    roi    flagship    time    intramural    accumulated    few    anxiety    conceived    detect    america    detects    wearables    19m    heavy    specialised    clinically    worldwide    despite    sudden    billion    attending    50m    institutes    least    lack    urgent    severe    people    more    deaths    patient    remote    trend    caused    medication    minimize    depression    self    33    die    seek    prevented    market    prevents    unexpected    nocturnal    90    epilepsy    off    monitoring    sleep    reduces    suffer    professionals    ai    device    independency    nightwatch    bracelet    wards    tested    critical    giving    profit    heart    company    adapting    patterns    2013    gt    seizures    full    uses    movement    tele       combination    death    improves    commercial    peace    leads    46   

Project "NIGHTWATCH" data sheet

The following table provides information about the project.

Coordinator
LIVASSURED BV 

Organization address
address: ALBERTUSSTRAAT 34
city: VUGHT
postcode: 5261AD
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2020-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LIVASSURED BV NL (VUGHT) coordinator 50˙000.00

Map

 Project objective

More than 50M people worldwide suffer from epilepsy, characterized by uncontrolled seizures, and about 30% find no relief from those despite taking medication. Nocturnal seizures can be critical; each year at least 33.000 people in EU die of Sudden Unexpected Death in Epilepsy (SUDEP), 40% of which could be prevented by attending the seizures on time. This is a continuous challenge for patients and caregivers, with important social and societal consequences (anxiety, depression, lack of sleep), and high intramural care costs (over €20 billion per year in EU). The NightWatch is a registered medical device that detects and notifies wirelessly remote caregivers in case of heavy nocturnal seizures in just few seconds. The bracelet uses a combination of heart rate and movement measurement, a unique AI algorithm conceived by three Dutch institutes specialised in epilepsy, automatically adapting to different patient patterns to minimize false alarm rate. It has been clinically tested and can detect > 90% of all types of urgent nocturnal seizures making it the most reliable system available. The NightWatch targets caregivers, patients and professionals who seek an effective alarm system for severe nocturnal seizures. It improves their quality of life giving them peace of mind, higher level of independency, reduces cost of care by reducing the need for intramural attention, and prevents deaths caused by SUDEP. With a trend to-wards home care and self-monitoring pushing market growth (expected to reach €4.0 billion in 2019), wearables becoming the preferred type of seizure monitoring. EU leads the seizure monitor devices market (46%), followed by North America (28%). NightWatch is the flagship product of LivAssured, a Dutch company created in 2013 as a spin-off to take over the commercial exploitation of the research results of the Tele-Epilepsy Consortium on nocturnal seizures. With its full commercial exploitation, we expect an accumulated profit of €19M and a ROI of 4

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "NIGHTWATCH" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "NIGHTWATCH" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Preemie (2019)

Personalised nutrition of low-birth-weight infants

Read More  

Proteus 25 (2018)

Developing the world’s first food wrapping machine with organic film

Read More  

Savesight (2020)

Contact lens embedded sensor for ocular hypertension and glaucoma monitoring

Read More